Active

RX FAVOREEL

Switched

BE0783537096

Rechtspersoon Private limited company 1 establishment

Eenbeekstraat 68, 9070 Destelbergen

Active for

4 year, 5 months

Financials

Financial year 2026

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 249,581

▲ 10477% vs 2025

Profit

Growing

€ 1.3 million

▲ 1069% vs 2025

Debts

High

€ 252,314

▼ 44% vs 2025

RX FAVOREEL from Destelbergen, company number BE0783537096, closed financial year 2026 with a result of € 1.3 million after tax. For that financial year RX FAVOREEL recorded a gross margin of € 249,581 and equity of € 1,117. Compared with financial year 2025, the result moved from € 110,894 to € 1.3 million. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What happened at RX FAVOREEL?

What happened at RX FAVOREEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2026: profit of € 1.3 million (▲ 1069% vs 2025). Source: NBB ↗
  • New establishment in Destelbergen. KBO
  • Niels Favoreel became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 5,883 loss in 2023 to € 1.3 million profit in 2026.

Paid € 64,794 in corporate taxes since 2023.

Best year ever: 2026, with € 1.3 million profit.

Paid out € 1.5 million in dividends to the owners in total.

A new publication or filing at RX FAVOREEL? We notify you, reason included.

Follow RX FAVOREEL

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Niels Favoreel

Behind RX FAVOREEL is Niels Favoreel. Niels Favoreel is also behind IATREION, Radiologie Dr. Favoreel, IMMORAD and RX Mariakerke.

See the full network in the app

Directors

According to the 2026 annual accounts

Niels Favoreel

Director

Also active at: IATREION, Radiologie Dr. Favoreel, IMMORAD +1 more

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Eenbeekstraat 68

9070 Destelbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0783.537.096
VAT number
BE 0783.537.096
Registered office
Eenbeekstraat 68, 9070 Destelbergen
Names & denominations
RX FAVOREEL
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
17 March 2022
Peppol
Active · Active since 27 Mar 2026

Frequently asked questions

What is the enterprise number of RX FAVOREEL?
The enterprise number of RX FAVOREEL is BE0783537096.
What is the address of RX FAVOREEL?
The registered office of RX FAVOREEL is located at Eenbeekstraat 68, 9070 Destelbergen.
When was RX FAVOREEL founded?
RX FAVOREEL was founded on 17 March 2022.
Does RX FAVOREEL have a website?
No website is currently known for RX FAVOREEL.
How much profit did RX FAVOREEL make in 2026?
RX FAVOREEL posted a profit after taxes of € 1,296,857 in financial year 2026.
What is the revenue of RX FAVOREEL?
As a small company, RX FAVOREEL is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 249,581.
How many employees does RX FAVOREEL have?
According to the 2026 annual accounts, RX FAVOREEL has 0 full-time equivalents (FTE).
Where can I find the annual accounts of RX FAVOREEL?
RX FAVOREEL files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of RX FAVOREEL?
According to the 2026 annual accounts, the directors of RX FAVOREEL are: Niels Favoreel.
Who owns RX FAVOREEL?
Behind RX FAVOREEL is Niels Favoreel. Niels Favoreel is also behind IATREION, Radiologie Dr. Favoreel, IMMORAD and RX Mariakerke.